The School of Pharmacy, supported by the State Key Laboratory of Antiviral Drugs and Pingyuan Laboratory, is committed to the full-chain R&D of innovative drugs to address major clinical needs in infectious diseases, chronic diseases, and mental disorders. Our research directions comprehensively cover the in-depth elucidation of viral mechanisms and novel target discovery, the rational design and synthesis of lead compounds (with a particular focus on nucleoside antiviral drugs), the development of advanced pharmaceutical formulations and delivery systems, as well as comprehensive druggability evaluation and preclinical research. Furthermore, by focusing on developing broad-spectrum and targeted antiviral therapies and overcoming drug resistance, we strive to translate fundamental research into novel therapeutics with fully independent intellectual property rights, ultimately serving the national Healthy China strategy.
